Quick Answer
BioNTech SE reported Total Assets of $21.99 billion for fiscal year 2025.
BioNTech SE Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.99B | -2.4% |
| 2024 | $22.53B | -2.1% |
| 2023 | $23.01B | -1.2% |
| 2022 | $23.28B | +47.0% |
| 2021 | $15.83B | +582.8% |
| 2020 | $2.32B | +190.7% |
| 2019 | $797.65M | +22.2% |
| 2018 | $652.99M | — |
- BioNTech SE showed a decrease of -2.4% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, BioNTech SE’s total assets has grown by 3267.4% (from $652.99 million to $21.99 billion).
- The most recent figure is from BioNTech SE’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: